Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer

By Buchegger Kurt   Riquelme Ismael   Viscarra Tamara   Ili Carmen   Brebi Priscilla   Huang Tim Hui-Ming   Roa Juan Carlos  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1525-1525

MDPI

Access to resources Recommend Favorite

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target

By Fierabracci Alessandra   Pellegrino Marsha  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-11 ,pp. : 1975-1975

MDPI

Access to resources Recommend Favorite

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

By Chua Melissa M.J.   Ortega Charina E.   Sheikh Ayesha   Lee Migi   Abdul-Rassoul Hussein   Hartshorn Kevan L.   Dominguez Isabel  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target

By Yee Nelson S.  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. : 39-39

MDPI

Access to resources Recommend Favorite

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer

By Johnson Rebecca   Sabnis Nirupama   McConathy Walter J.   Lacko Andras G.  

Pharmaceutics, Vol. 5, Iss. 2, 2013-06 ,pp. : 353-370

MDPI

Access to resources Recommend Favorite